Skip to main content

Table 1 Distribution of patients in inoperable and irresectable group

From: Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma

Reason inoperable n = 33

 

Comorbidity cardiovascular n (%)

2 (6%)

Comorbidity respiratory n (%)

14 (42%)

Comorbidity performancestatus n (%)

10 (30%)

Comorbidity other n (%)

7 (2%)

Reason irresectable n = 94

 

T4a n (%)

15 (16%)

T4b n (%)

9 (10%)

Recurrent carcinoma n (%)

19 (20%

Cervical carcinoma n (%)

9 (10%)

M1a disease n (%)

41 (44%)